{"id":"W2059255702","doi":"10.1007/s10637-014-0106-5","title":"A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients","year":2014,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Docetaxel; Dasatinib; Medicine; Prostate cancer; Oncology; Cancer; Internal medicine; Prostate; Pharmacology; Tyrosine kinase; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002338888,0.002216197,0.005246327,0.0006613592,0.0007244442,0.001841744,0.001606901,0.00204151,0.007915541],"category_scores_gemma":[0.002413767,0.001397737,0.002639798,0.0007139232,0.002372337,0.002372576,0.0006911815,0.005736419,0.001507098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001541553,"about_ca_system_score_gemma":0.002070746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001480899,"about_ca_topic_score_gemma":0.003555155,"domain_scores_codex":[0.9989484,0.000531325,0.00006035225,0.0002164841,0.00006318567,0.0001802672],"domain_scores_gemma":[0.9981501,0.0004292165,0.000312737,0.0001818991,0.00009061965,0.0008354742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9815921,0.008564121,0.0004075356,0.0001684823,0.0005550965,0.00002332097,0.00003865021,0.0003237732,0.001605871,0.00007788199,0.0003838114,0.006259311],"study_design_scores_gemma":[0.9336358,0.06441218,0.000805063,0.00000764369,0.0002738294,0.00002066682,0.00001873507,0.0002193769,0.000164906,0.00009923374,0.0003290022,0.00001349295],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873482,0.003131163,0.0007673171,0.0009911752,0.0008231161,0.003780653,0.001046369,0.0001107788,0.002001276],"genre_scores_gemma":[0.9861478,0.002069303,0.001908405,0.00140123,0.000601854,0.003380124,0.001462438,0.00004847416,0.002980348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007915541,"threshold_uncertainty_score":0.02648008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03335540329604145,"score_gpt":0.3297910892392198,"score_spread":0.2964356859431784,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}